TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 30 filers reported holding TSCAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $96,000 | – | 11,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $2,835,000 | 16.79% |
| DC Investments Management, LLC | 35,563 | $160,000 | 0.23% |
| Deer Management Co. LLC | 1,245,505 | $5,605,000 | 0.14% |
| Alphabet Inc. | 1,077,080 | $4,847,000 | 0.12% |
| RA Capital Management | 1,255,317 | $5,649,000 | 0.10% |
| HHLR ADVISORS, LTD. | 1,282,976 | $5,773,000 | 0.09% |
| Nan Fung Group Holdings Ltd | 48,600 | $219,000 | 0.06% |
| Baker Brothers Advisors | 1,425,000 | $6,413,000 | 0.03% |
| Tekla Capital Management LLC | 200,000 | $900,000 | 0.03% |
| Marquette Asset Management, LLC | 21,618 | $97,000 | 0.02% |